Modulators of 5-HT receptors and methods of use thereof

The present application relates to aryl- and heteroaryl-fused decahydropyrroloazepine, octahydrooxepinopyrrole, octahydropyrrolothiazepine dioxide, decahydrocyclohepta[c]pyrrole, and octahydrocyclohepta[c]pyrrole derivatives of formula (I) wherein R1, R2, R3, R4, R5, A, Y1, Y2, and Y3 are as defined...

Full description

Saved in:
Bibliographic Details
Main Authors WELCH DENNIE S, ZHAO HONGYU, WILSON NOEL S, AKRITOPOULOU-ZANZE IRINI, BRAJE WILFRIED, THOMPSON CHRISTINA M, TURNER SEAN C, KRUGER ALBERT W, SHEKHAR SHASHANK, LI HUANQIU, ZHANG MIN, RELO ANA-LUCIA, GASIECKI ALAN F, DJURIC STEVAN W, GANDARILLA JORGE
Format Patent
LanguageEnglish
Published 17.11.2015
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present application relates to aryl- and heteroaryl-fused decahydropyrroloazepine, octahydrooxepinopyrrole, octahydropyrrolothiazepine dioxide, decahydrocyclohepta[c]pyrrole, and octahydrocyclohepta[c]pyrrole derivatives of formula (I) wherein R1, R2, R3, R4, R5, A, Y1, Y2, and Y3 are as defined in the specification. The present application also relates to compositions comprising such compounds, processes for making such compounds, and methods of treating disease conditions using such compounds and compositions, and methods for identifying such compounds.
Bibliography:Application Number: US20100784624